Online Business

Insurers wait yet another year for increase in FDI

The year 2009 saw insurance firms waiting for easing of foreign direct investment (FDI) norms, just as they have done every year for the last five years, but there is promise of the law being amended to this effect next year. - Madan Sabnavis: Don"t ignore External Commercial Borrowings">Madan Sabnavis: Don"t ignore External Commercial Borrowings - Govt in pre-Xmas reforms drive - Govt to soon clarify new banking FDI norms - Govt to review FDI rules every six months - FDI jumps 60% to $1.74 bn in Nov - Global crisis pinches FDI purse in 2009 The government had first mentioned raising FDI ceiling in insurance sector to 49 per cent from the current 26 per cent in the 2004 Union Budget and introduced a Bill to do so over a year ago. The Insurance Laws (Amendment) Bill, 2008, has since been referred to a Parliamentary Standing Committee. The Parliamentary panel"s report is expected before the Budget session in February next year and passage of the Bill is likely during the same year. Although the global financial meltdown of last year hit top insurers like AIG, life insurers in India have seen new business premium collections rise 10-fold over as many years. The new premium collection has increased to Rs 86,983 crore in 2009 compared to Rs 8,299 crore 10 years ago when the sector was opened to private players. There are 23 life insurance companies and 21 general insurers operating in the country, but their growth potential has not been tapped for want for capital -- which could be addressed through raising FDI ceiling. "The FDI ceiling, if increased, could bring in the much-needed capital for the growth of the sector, as well as for the nation, as insurance players provide long term capital for development of infrastructure," DLF Pramerica Managing Director Kapil Mehta said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Sun Pharma gets support of Templeton against Taro
Sun Pharma has got a shot in the arm in its ongoing takeover battle with Israeli drug firm Taro as investor firm Templeton has announced its intention to vote against the Taro board in upcoming annual general meeting later this month.
Popular Articles
payday loans no faxing

Power tariffs hiked by 22% in Bengal
Rising coal prices cited as reason.

Setback for Reliance Power's Dadri plant
HC quashes use of emergency power for land buys; ADAG firm says it’s a procedural issue.